A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
Status:
Completed
Trial end date:
2020-04-23
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, active-controlled, non-inferiority, phase 3
study to evaluate the efficacy and safety of MCT-SR in patients with gastritis.